Medical Forum / Diseases and Disorders / Cancer / March 2004
Basal cell nodular type on nose
|
|
Thread rating:  |
D&G - 16 Nov 2003 17:30 GMT Hi I am new to this group. Just diagnosed with a basal cell carcinoma (non-sclerotic type) on the tip of my nose. I am a redhead and new it was inevitable. Just not so soon, and not on the tip of my nose. I am debating on treatment type. Cryo vs. Mohs vs. 5-fu vs. etc. Can any one give me any advise on treatment type and results. I am female and I'm very concerned about reoccurrence and scarring. HELP.
Thanks, Gin
Sharon - 16 Nov 2003 17:34 GMT "D&G" <dgmagr@swbell.net> wrote in message
> Cryo vs. Mohs vs. 5-fu vs. etc. Can any > one give me any advise on treatment type and results. I am female and I'm > very concerned about reoccurrence and scarring. HELP. I have never experienced this disease but my Uncle John is a "two time hitter". You can see a pic of him here: http://www.rare-cancer.org/person1.html and a little of his story here: http://www.rare-cancer.org/three.html#john
His MOH's went very well and I do not see a lot of scarring. My Uncle John has always told me that he is willing to share his experience with anyone that it would help. Would you like me to give you his email addie?
Take Care, Sharon
J - 17 Nov 2003 07:07 GMT > "D&G" <dgmagr@swbell.net> wrote in message > > Cryo vs. Mohs vs. 5-fu vs. etc. Can any [quoted text clipped - 5 lines] > and a little of his story here: > http://www.rare-cancer.org/three.html#john I saw nothing whatsoever there of assist to the poster except a one-sentence PS about your uncle's basal cell.. Basal cell carcinoma is not rare. Basal cell carcinoma is the most common form of cancer in the US. It accounts for about 75% of all skin cancers. So what's your point in posting those, Sharon? Looking for donations? J
Sharon - 17 Nov 2003 12:15 GMT "J" <BigWink@invalid.inv> wrote in message > So what's your point in posting those, Sharon?
> Looking for donations? > J The point was to let her see what my Uncle looked like after the MOH's. And to let her see that he really did have BCC. You would have to drill down pretty far in that website to see the donations links. And that link only takes you to other rare cancer websites for their research links. I didn't send her any of those links, I sent her to specific pages, so she wouldn't have to bother with the rest of the website. Take Care, Sharon
J - 16 Nov 2003 20:45 GMT > Hi I am new to this group. Just diagnosed with a basal cell carcinoma > (non-sclerotic type) on the tip of my nose. I am a redhead and new it was > inevitable. Just not so soon, and not on the tip of my nose. > I am debating on treatment type. Cryo vs. Mohs vs. 5-fu vs. etc. Can any > one give me any advise on treatment type and results. I am female and I'm > very concerned about reoccurrence and scarring. HELP. Hello Gin, What's the size? When do you need to make your decision? Have you had scarring problems before? Have you talked to a dermy or surgeon for an opinion?
Steph should be along...
Earlier he replied "A dermatologist or a surgeon if you like the idea of surgery. I would see a radiation oncologist every time...."
Hang in there for Steph, if you can.
J
Steph - 17 Nov 2003 03:12 GMT > > Hi I am new to this group. Just diagnosed with a basal cell carcinoma > > (non-sclerotic type) on the tip of my nose. I am a redhead and new it was [quoted text clipped - 17 lines] > > J You already gave my answer, J
Peter Moran - 17 Nov 2003 06:48 GMT > > > Hi I am new to this group. Just diagnosed with a basal cell carcinoma > > > (non-sclerotic type) on the tip of my nose. I am a redhead and new it [quoted text clipped - 22 lines] > > You already gave my answer, J Radiotherapy in the long term usually leaves a depressed, pale, thin, telangiectatic scar and has at least as high a recurrence rate as surgery. Our local radiotherapists no longer treat cutaneous BCCs, but that may be due to volume of work in Australia.
I would see a good plastic surgeon if you want the best long term .
Peter Moran.
Steph - 17 Nov 2003 08:08 GMT > > > > Hi I am new to this group. Just diagnosed with a basal cell carcinoma > > > > (non-sclerotic type) on the tip of my nose. I am a redhead and new it [quoted text clipped - 31 lines] > > Peter Moran. As I've always said, good radiotherapy or good surgery is the best treatment for BCC.
I see a lot of recurrences after bad surgery......
And all the literature suggests that patients find the cosmetic result after RT every bit as good or better than after surgery.
Peter Moran - 17 Nov 2003 20:49 GMT > "Peter Moran" <moringa@gil.com.au> wrote in message news:3fb86f50$0$15338$61c65585@uq-127creek-reader-02.brisbane.pipenetworks.com.au...
> > > > > Hi I am new to this group. Just diagnosed with a basal cell > carcinoma [quoted text clipped - 41 lines] > > I see a lot of recurrences after bad surgery...... I agree with that. But the recurrence rate should be near zero with surgery for a simple nodular BCC.
> And all the literature suggests that patients find the cosmetic result after > RT every bit as good or better than after surgery. I also agree with that at any early follow up. But refer me to such a study at ten, twenty, or thirty years.
Peter Moran
Steph - 18 Nov 2003 03:14 GMT > > "Peter Moran" <moringa@gil.com.au> wrote in message news:3fb86f50$0$15338$61c65585@uq-127creek-reader-02.brisbane.pipenetworks.com.au...
> > > > > > Hi I am new to this group. Just diagnosed with a basal cell > > carcinoma [quoted text clipped - 49 lines] > I agree with that. But the recurrence rate should be near zero with surgery > for a simple nodular BCC. As it should be with radiotherapy..........
> > And all the literature suggests that patients find the cosmetic result > after [quoted text clipped - 4 lines] > > Peter Moran Ditto, Peter
Peter Moran - 18 Nov 2003 21:43 GMT > "Peter Moran" <moringa@gil.com.au> wrote in message news:3fb9344a$0$15338$61c65585@uq-127creek-reader-02.brisbane.pipenetworks.com.au...
> > > "Peter Moran" <moringa@gil.com.au> wrote in message <snip>
> > > And all the literature suggests that patients find the cosmetic result > > after [quoted text clipped - 7 lines] > > Ditto, Peter OK. The following randomised trial demonstrates what I suggest, that the cosmetic outcome with radiotherapy deteriorates with time.
.Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face.
Petit JY, Avril MF, Margulis A, Chassagne D, Gerbaulet A, Duvillard P, Auperin A, Rietjens M.
Plastic Surgery Department, European Institute of Oncology, Milan, Italy. jypetit@ieo.cilea.it
Basal cell carcinoma is the most frequent cutaneous carcinoma, and it is characterized by its local spreading and an exceptional tendency to metastasize. Radical excision or destruction ensures the highest chance of cure. The most frequent site of this tumor is the face, where radical excision is limited by the proximity of essential anatomic structures. The main difficulty is to avoid mutilation and to provide good cosmetic results despite the vicinity of the eyes, the nose, and the mouth. Surgery and radiotherapy are known to provide similar chances of cure, but results concerning cosmetic sequelae are controversial, depending sometimes on the specialty of the physician in charge of the treatment. A randomized trial was performed at the Gustave-Roussy Institute to compare basal cell carcinomas of the face treated either by surgery or by radiotherapy. In summary, a significant advantage was observed in favor of surgery, as has been published elsewhere. Looking at the details of the cosmetic results, we analyzed the specific methodology of the cosmetic evaluation set up to eradicate the usual bias owing to subjective judgments. We looked also to the evolution of the cosmetic results with time. A panel of five judges performed repeated evaluations during the follow-up, and standardized photographs were taken at each visit and rated later by three nonmedical judges. In total, 174 patients were treated by surgery and 173 by radiotherapy; the choice of the treatment was allocated by randomization. Postoperative complications were higher in the radiotherapy group. The final cosmetic results after 4 years of follow-up were rated significantly better with surgery than with radiotherapy (good in 87 percent versus 69 percent according to the patient, 79 percent versus 40 percent according to the dermatologist, and respectively for each of the observers). Evolution of the ratings during the follow-up demonstrated an improvement of the cosmesis after surgery and stable or deteriorated results after radiotherapy. The same trend was observed regardless of the site of the tumor on the face, except for the nose, where the difference--still in favor of the surgery--was not significant. Concordance of all assessments in our study was the main guarantee of reliability of our methodology for cosmetic evaluation.
Another for good luck. The face heals very well and scars tend to disappear with time. There can be no question that the changes I described increase with time after radiotheapy.
Br J Cancer. 1997;76(1):100-6. Related Articles, Links
Comment in: a.. Br J Cancer. 1998 Nov;78(9):1257.
Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study.
Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, Guillaume JC, Chalon R, Petit JY, Sancho-Garnier H, Prade M, Bouzy J, Chassagne D.
Service de dermatologie, Institut Gustave Roussy, Villejuif, France.
Basal cell carcinomas (BCCs) are very frequent cutaneous cancers, often located on the face. Cure rates with surgery and radiotherapy are high, but these treatments have never been compared prospectively. A randomized trial was initiated in 1982 to compare surgery and radiotherapy in the treatment of primary BCC of the face measuring less than 4 cm. The primary end point was the failure rate (persistent or recurrent disease) after 4 years of follow-up. The secondary end point was the cosmetic results assessed by the patient, the dermatologist and three persons not involved in the trial. In the course of the trial, 347 patients were treated. Of the 174 patients in the surgery group, 71% had local anaesthesia and 91% frozen section examination. Of the 173 patients in the radiotherapy group, 55% were treated with interstitial brachytherapy, 33% with contactherapy and 12% with conventional radiotherapy. The 4-year actuarial failure rate (95% CI) was 0.7% (0.1-3.9%) in the surgery group compared with 7.5% (4.2-13.1%) in the radiotherapy group (log-rank P = 0.003). The cosmetic results assessed by four of the five judges were significantly better after surgery than after radiotherapy. Eighty-seven per cent of the surgery-treated patients and 69% of the radiation-treated patients considered the cosmetic result as good (P < 0.01). Thus, in the treatment of BCC of the face of less than 4 cm in diameter, surgery should be preferred to radiotherapy.
Peter Moran
doe - 18 Nov 2003 22:04 GMT >Subject: Re: Basal cell nodular type on nose Carcinogenesis. 2003 Mar;24(3):555-63. Related Articles, Links
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
Singh RP, Agarwal C, Agarwal R.
Department of Pharmaceutical Sciences, School of Pharmacy and University of Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Cancer chemopreventive effects of inositol hexaphosphate (IP6), a dietary constituent, have been demonstrated against a variety of experimental tumors, however, limited studies have been done against prostate cancer (PCA), and molecular mechanisms are not well defined. In the present study, we investigated the growth inhibitory effect and associated mechanisms of IP6 in advanced human PCA cells. Advanced human prostate carcinoma DU145 cells were used to study the anticancer effect of IP6. Flow cytometric analysis was performed for cell cycle progression and apoptosis studies. Western immunoblotting, immunoprecipitation and kinase assay were performed to investigate the involvement of G1 cell cycle regulators and their interplay, and end point markers of apoptosis. A significant dose- as well as time-dependent growth inhibition was observed in IP6-treated cells, which was associated with an increase in G1 arrest. IP6 strongly increased the expression of CDKIs (cyclin-dependent kinase inhibitors), Cip1/p21 and Kip1/p27, without any noticeable changes in G1 CDKs and cyclins, except a slight increase in cyclin D2. IP6 inhibited kinase activities associated with CDK2, 4 and 6, and cyclin E and D1. Further studies showed the increased binding of Kip1/p27 and Cip1/p21 with cyclin D1 and E. In down-stream of CDKI-CDK/cyclin cascade, IP6 increased hypophosphorylated levels of Rb-related proteins, pRb/p107 and pRb2/p130, and moderately decreased E2F4 but increased its binding to both pRb/p107 and pRb2/p130. At higher doses and longer treatment times, IP6 caused a marked increase in apoptosis, which was accompanied by increased levels of cleaved PARP and active caspase 3. IP6 modulates CDKI-CDK-cyclin complex, and decreases CDK-cyclin kinase activity, possibly leading to hypophosphorylation of Rb-related proteins and an increased sequestration of E2F4. Higher doses of IP6 could induce apoptosis and that might involve caspases activation. These molecular alterations provide an insight into IP6-caused growth inhibition, G1 arrest and apoptotic death of human prostate carcinoma DU145 cells.
PMID: 12663518 [PubMed - indexed for MEDLINE]
-------------------------------------------------------------------------- ------
Who loves ya. Tom
 Signature Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking
Steph - 19 Nov 2003 02:22 GMT > > "Peter Moran" <moringa@gil.com.au> wrote in message news:3fb9344a$0$15338$61c65585@uq-127creek-reader-02.brisbane.pipenetworks.com.au...
> > > > "Peter Moran" <moringa@gil.com.au> wrote in message > > > [quoted text clipped - 98 lines] > > Peter Moran Peter, It's the same group of patients in both studies! This is a very unusual group of patients "Of the 173 patients in the radiotherapy group, 55% were treated with interstitial brachytherapy, 33% with contactherapy and 12% with conventional radiotherapy." Over half the patients had interstitial brachytherapy. In BC, less than 0.5% of patients with skin cancers are treated by interstitial brachytherapy (which is surgery, by the way, as well as radiotherapy). And less than 1% of skin cancers treated by radiotherapy are treated by interstitial. Have you seen the size of a caesium needle? I'm not surprised by these silly results in a silly study
Peter Moran - 19 Nov 2003 20:28 GMT > "Peter Moran" <moringa@gil.com.au> wrote in message > news:3fba9264$0$29936$61c65585@uq-127creek-reader-> > [quoted text clipped - 5 lines] > with contactherapy and 12% with conventional radiotherapy." Over half the > patients had interstitial brachytherapy. I did miss that sentence. I agree this is odd, unless they were dealing with a lot of bulky tumours, which is possible in Italy.
I don't think it necessarily contradicts the conclusions.
Not surprisingly there are no other randomised studies that i can find on the question, so we are left with a difference of opinion, and possibly us each seeing the results of different techniques, although few sites in the world would have more experience and expertise in the treatment of BCCa as the QRI in Brisbane, Australia. I must ask if you have you had the opportunity to see any of your personal results ten, fifteen years, twenty years down the track? The effects of radiotherapy on the skin evolve forever.
Peter Moran
Steph - 20 Nov 2003 06:40 GMT > > "Peter Moran" <moringa@gil.com.au> wrote in message > > news:3fba9264$0$29936$61c65585@uq-127creek-reader-> > [quoted text clipped - 21 lines] > > Peter Moran Yes, I see plenty of patients 10, 15 and 20 years after radiotherapy. Most of them are very pleased with the results, and come back for other tumours to be treated. I also see a steady stream of recurrences after Moh's magical mystery treatment. And after Moh's for a large BCC, with a skin graft in place, the cosmesis is terrible, and recurrences are deep and noticed late, by which time they are often fixed to the underlying skull or facial bones and are a bugger to treat.......
The "trial" you found is the only one I could find going back to 1960, Peter. I think it's the only randomised study. But whatever it says, it has very little to do with the bread and butter of treating BCCs and SCCs of less than 4 cm in size.
The effects of radiotherapy may evolve forever in some people, but so do the effects of ageing. There are many patients who had radiotherapy 10 or more years ago for small skin cancers in whom I can't even find the area treated..........
madiba - 20 Nov 2003 18:40 GMT > "Peter Moran" <moringa@gil.com.au> wrote in message > > OK. The following randomised trial demonstrates what I suggest, that the > > cosmetic outcome with radiotherapy deteriorates with time. DeVita has said this for decades..
<snip>
> > Peter Moran > [quoted text clipped - 8 lines] > radiotherapy are treated by interstitial. Have you seen the size of a > caesium needle? I'm not surprised by these silly results in a silly study These studies were done by the french who have a long history of very elegant brachytherapy of skin tumours. They threaded thin (Ra?) wires s.c., the results were also cosmetically very good. Nowdays I imagine they thread thin catheters s.c. to take small Ir-192 sources..
 Signature madiba
D&G - 19 Nov 2003 22:06 GMT Hi J
It seems to be about a 1cm x 1cm (approximately) It is hard to see, it is very faint. But its on the tip of my nose. I need to make a decision as soon as possible. I have not had a huge problem with scaring, but I am a surgical nurse and I see the things we do in the OR. I have talked to one dermatologist and many surgeons from plastic to general to ENT. I get a huge difference of opinion so I wanted to talk to someone that might have experienced it first hand. I go to see an ENT/Plastic tomorrow for another OFFICIAL opinion. Thanks Gin
> > Hi I am new to this group. Just diagnosed with a basal cell carcinoma > > (non-sclerotic type) on the tip of my nose. I am a redhead and new it was [quoted text clipped - 17 lines] > > J Sharon - 19 Nov 2003 21:58 GMT "D&G" <dgmagr@swbell.net> wrote in message
>I get a huge difference of opinion so I wanted to talk to > someone that might have experienced it first hand. I go to see an > ENT/Plastic tomorrow for another OFFICIAL opinion. > Thanks > Gin I had emailed before, but I will just tell you once again Gin. My Uncle had the MOH's surgery for his basal cell carcinoma. My Mom also had a carcinoma removed surgically from her nose. My Mom's experience is limited, since she does not ask questions or keep track of info. Ski-jump noses run in my family. Even with sunblock, they get burned.
In any event, my Uncle John has always told me that he is willing to talk to any patient that he can help with information. Would you like to have his email addie. If so, email me privately and I will send it privately. I do not want him to be inundated with newgroup spamming. Please take the 'spam' out of my addie when you email.
Take Care, Sharon
Steph - 20 Nov 2003 06:42 GMT > Hi J > [quoted text clipped - 8 lines] > Thanks > Gin It wouldn't do any harm to get and "official" opinion from a radiation oncologist either! Dermatologists and surgeons are pretty free with their opinions on what radiation can and cannot do, usually without knowing much about the subject...
doe - 20 Nov 2003 07:07 GMT >Subject: Re: Basal cell nodular type on nose
>Oncologists are pretty free with their >opinions usually without knowing much ...
Couldn't have said it better myself ..
Who loves ya. Tom
 Signature Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking
Mike Radcliffe - 20 Nov 2003 07:32 GMT > >Subject: Re: Basal cell nodular type on nose > [quoted text clipped - 6 lines] > Who loves ya. > Tom Strikes me they know about oncology and radiation and can read and understand simple english unlike some iron deficient spammers I know. MIKE
doe - 20 Nov 2003 09:10 GMT >Subject: Re: Basal cell nodular type on nose >From: "Mike Radcliffe" mikeradcliffenospam@bigpond.com [quoted text clipped - 15 lines] >understand simple english unlike some iron deficient spammers I know. >MIKE As if you could compete ..
F .. O ..
Who loves ya. Tom
 Signature Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking
Mike Radcliffe - 20 Nov 2003 07:19 GMT > > Hi J > > [quoted text clipped - 14 lines] > opinions on what radiation can and cannot do, usually without knowing much > about the subject... In Fremantle Australia the ENT clinic sees all the cancer patients in one session one day a week and is attended in one room by the oncologist, radiation oncologist, ent and plastic surgeons. All options and opinions can be advanced and discussed. It's a bit daunting for patients to see so many specialists at one time but at least all medical opinions are represented at one time and saves the patient having to slog around looking for different opinions....if they even knew there were different opinions to be had. I know the chest clinics have the same sort of system for their patients. I think the same is true for other hospitals in the the area but if it isn't it should be and should be universal in cultures boasting advanced medical amenities. I don't know if other medical specialties like gastroenterology, dermatology, genito-urology etc have the same system but it would seem to be almost criminal not to. MIKE
doe - 20 Nov 2003 09:10 GMT >Subject: Re: Basal cell nodular type on nose >From: "Mike Radcliffe" <<snip>>
Who loves ya. Tom
 Signature Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking
madiba - 20 Nov 2003 20:04 GMT > I don't know if other medical specialties like gastroenterology, > dermatology, genito-urology etc have the same system but it would seem to > be almost criminal not to. Oh its very 'en vogue' in the UK, rad. oncologists spend lots of their time in such meetings. Leaves little time for proper treatment planning.. Its still catching on in the continental EU.
 Signature madiba
Mike Radcliffe - 21 Nov 2003 08:41 GMT > > I don't know if other medical specialties like gastroenterology, > > dermatology, genito-urology etc have the same system but it would seem to > > be almost criminal not to. > Oh its very 'en vogue' in the UK, rad. oncologists spend lots of their > time in such meetings. Leaves little time for proper treatment > planning.. Its still catching on in the continental EU. Treatment planning is of no value unless the appropriate treatment is agreed upon in the first place. Most radiation oncologists have plenty of time to plan treatment; it's lack of machine time that is usually the problem, I am fairly sure. MIKE
Steph - 21 Nov 2003 16:32 GMT > > > I don't know if other medical specialties like gastroenterology, > > > dermatology, genito-urology etc have the same system but it would seem [quoted text clipped - 9 lines] > lack of machine time that is usually the problem, I am fairly sure. > MIKE We do all the team political correctness stuff in BC. It doesn't cut into clinical time, just breakfast and lunch and supper............
madiba - 22 Nov 2003 14:23 GMT > > > > I don't know if other medical specialties like gastroenterology, > > > > dermatology, genito-urology etc have the same system but it would seem [quoted text clipped - 8 lines] > > Most radiation oncologists have plenty of time to plan treatment; it's > > lack of machine time that is usually the problem, I am fairly sure. No, also serious med. manpower shortages, but Tony B is working on the problem (both aspects)..
> > MIKE > > > We do all the team political correctness stuff in BC. > It doesn't cut into clinical time, just breakfast and lunch and > supper............ LOL On the Continent nothing is more important than the lunch break..
 Signature madiba
madiba - 20 Nov 2003 20:04 GMT > Hi J > [quoted text clipped - 6 lines] > someone that might have experienced it first hand. I go to see an > ENT/Plastic tomorrow for another OFFICIAL opinion. Radiotherapy is most suitable for nose tip tumors. Peter Moran has a valid point about long-term cosmetic results after RT and being located in Australia he presumably has a vast amount of experience with this cancer. However its difficult to get good surgical results at certain locations on the face, so ask whoever you go to which method brings the best results at your tumor site.
 Signature madiba
Peter Moran - 20 Nov 2003 20:14 GMT > > Hi J > > [quoted text clipped - 12 lines] > locations on the face, so ask whoever you go to which method brings the > best results at your tumor site. I agree with this. A BCC of this size on the tip of the nose will probably need a full thickness skin graft, with variable, but often poor cosmetic outcomes. This is an instance where radiotetherapy, if available, will give better results in the short term.
Peter Moran
madiba - 28 Mar 2004 23:39 GMT > "madiba" <down@thekraal.com> wrote in message
> > Radiotherapy is most suitable for nose tip tumors. Peter Moran has a > > valid point about long-term cosmetic results after RT and being located > > in Australia he presumably has a vast amount of experience with this > > cancer. However its difficult to get good surgical results at certain > > locations on the face, so ask whoever you go to which method brings the > > best results at your tumor site.
> I agree with this. A BCC of this size on the tip of the nose will probably > need a full thickness skin graft, with variable, but often poor cosmetic > outcomes. This is an instance where radiotetherapy, if available, will > give better results in the short term. There is now a 5% Imiquimod creme (Aldara®) available that does the job by stimulating the immune response to destroy the BCC. Very good results with superficial lesions, also with solar keratoses and all kinds of warts (HPV). Less promising with melanoma and deep tumors.
 Signature madiba
J - 17 Nov 2003 07:07 GMT > Hi I am new to this group. Just diagnosed with a basal cell carcinoma > (non-sclerotic type) on the tip of my nose. I am a redhead and new it was > inevitable. Just not so soon, and not on the tip of my nose. > I am debating on treatment type. Cryo vs. Mohs vs. 5-fu vs. etc. Can any > one give me any advise on treatment type and results. I am female and I'm > very concerned about reoccurrence and scarring. HELP. Gin, since you seem to be in the south US, you'd do well to wear a wide brimmed hat and avoid the sun during peak hours and/or over-exposures. oh and make sure that someone, from time to time, checks your scalp and other areas that you cannot see. http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm J
D&G - 19 Nov 2003 22:13 GMT Hi J
Yes I am in my early 40's I have worn sunscreen on my face, neck, chest, and arms everyday for 20 years. Mostly I avoid the sun completely. I run from shade to shade. This ca is probably due to damage done when I was a child (before sunscreen and the media push for it.) Great advice although. As for checking my skin . . . I will see my dermo every 6 mo from now on. Wish I would have started earlier.
Thanks again, Gin
> > Hi I am new to this group. Just diagnosed with a basal cell carcinoma > > (non-sclerotic type) on the tip of my nose. I am a redhead and new it was [quoted text clipped - 9 lines] > http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm > J Tm n Kat - 18 Nov 2003 01:52 GMT >Subject: Basal cell nodular type on nose >From: "D&G" dgmagr@swbell.net >Date: 11/16/2003
>Hi I am new to this group. Just diagnosed with a basal cell carcinoma >(non-sclerotic type) on the tip of my nose. I am a redhead and new it was [quoted text clipped - 5 lines] >Thanks, >Gin I went to a plastic surgeon whose office was adjacent to a hospital.Sent the biopsy over and got the (margin) results before he closed the wound. That worked well for me but it was a small enough area where he could do it in his office. Dr Dean Odeal was just talking about his experience on his radio show this past weekend and he had the Mohs procedure. Kathy J
Ron Peterson - 25 Nov 2003 19:44 GMT > Hi I am new to this group. Just diagnosed with a basal cell carcinoma > (non-sclerotic type) on the tip of my nose. I am a redhead and new it was > inevitable. Just not so soon, and not on the tip of my nose. > I am debating on treatment type. Cryo vs. Mohs vs. 5-fu vs. etc. Can any > one give me any advise on treatment type and results. I am female and I'm > very concerned about reoccurrence and scarring. HELP. I have had Moh's chemosurgery a few times and have been pleased with the results. The advantage of Moh's technique is that a minimal amount of tissue is removed which results in less scarring. I haven't had any reoccurance at those sites, but am pretty good about wearing sunblock.
 Signature Ron
|
|
|